 |
|
How Useful Is the Rheumatoid Factor?An Analysis of Sensitivity, Specificity, and Predictive Value
Robert H. Shmerling, MD;
Thomas L. Delbanco, MD
Arch Intern Med. 1992;152(12):2417-2420.
Abstract
Background.—
The rheumatoid factor (RF) is frequently ordered in an effort to detect disease, yet its diagnostic utility has not been thoroughly examined. To determine the test's sensitivity, specificity, positive predictive value, and negative predictive value, we analyzed tests ordered in our institution.
Methods.—
We performed a retrospective analysis of all 86 patients with a positive RF over a 6-month period identified consecutively soon after the test was ordered. A similar analysis was applied to 86 seronegative patients selected at random from a total seronegative population of 477 during the same period. The patients represented the primary care and subspecialty practices and inpatient wards of a 504-bed university teaching hospital.
Results.—
A positive RF result was strongly associated with rheumatoid arthritis or another rheumatic disease. For rheumatoid arthritis, sensitivity=0.28 and specificity=0.87, while for any rheumatic disease, sensitivity=0.29 and specificity=0.88. The positive predictive values for rheumatoid arthritis and any rheumatic disease were 0.24 and 0.34, respectively, and the negative predictive values were 0.89 and 0.85, respectively. Seropositive patients were slightly older (55 vs 49 years old), but the incidence of false-positive RFs among the elderly (69%) was not significantly higher than among younger patients (65%). The cost per true-positive RF result was $563.
Conclusions.—
In this study, most positive RF results were not helpful since the majority represented false-positive results. The low positive predictive value of the RF casts doubt on the utility of the RF in the diagnostic evaluation of patients. Contrary to traditional clinical expectations, the diagnostic utility of the RF may be greatest when it is negative. However, the subset of patients with seronegative rheumatic disease reduces the test's power to exclude such disorders even when the RF is negative. Given the test's limitations, clinicians should reconsider their expectations when ordering an RF. The utility of the RF may improve if it is ordered more selectively.
(Arch Intern Med. 1992;152:2417-2420)
Author Affiliations
From the Division of General Medicine and Primary Care and the Division of Rheumatology, Department of Medicine, Beth Israel Hospital, Harvard Medical School, the Charles A. Dana Research Institute, and the Harvard-Thorndike Laboratory, Boston, Mass.
Footnotes
Accepted for publication June 24, 1992.
Reprint requests to Healthcare Associates at Longwood, 333 Longwood Ave, 3rd Floor, Boston, MA 02115 (Dr Shmerling).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Testing for Anti-Cyclic Citrullinated Peptide Antibodies: Is It Time to Set This Genie Free?
Shmerling
Arch Intern Med 2009;169:9-14.
FULL TEXT
Meta-analysis: Diagnostic Accuracy of Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
Nishimura et al.
ANN INTERN MED 2007;146:797-808.
ABSTRACT
| FULL TEXT
Treatment of rheumatoid arthritis
Gaffo et al.
Am J Health Syst Pharm 2006;63:2451-2465.
ABSTRACT
| FULL TEXT
Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)
Kastbom et al.
Ann Rheum Dis 2004;63:1085-1089.
ABSTRACT
| FULL TEXT
Evidence-Based Use of Rheumatologic Laboratory Tests
Kavanaugh
Arch Intern Med 2004;164:109-109.
FULL TEXT
Ordering and Interpreting Rheumatologic Laboratory Tests
Gardner and Kadel
J Am Acad Orthop Surg 2003;11:60-67.
ABSTRACT
| FULL TEXT
Rheumatic Findings in Gulf War Veterans
Grady et al.
Arch Intern Med 1998;158:367-371.
ABSTRACT
| FULL TEXT
Antinuclear Antibody Testing: A Study of Clinical Utility
Slater et al.
Arch Intern Med 1996;156:1421-1425.
ABSTRACT
The Utility of the Rheumatoid Factor
Cusato and Bush
Arch Intern Med 1993;153:1937-1938.
ABSTRACT
The Utility of the Rheumatoid Factor-Reply
Shmerling and Delbanco
Arch Intern Med 1993;153:1938-1938.
ABSTRACT
RHEUMATOID FACTOR RECONSIDERED
JWatch General 1992;1992:4-4.
FULL TEXT
|
